Clinical Trial Update: Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis

View source ↗

Summary

A clinical trial update describing long-term follow-up of immune checkpoint inhibitor–induced ileocolitis and ongoing recruitment for patients with advanced mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Immune Checkpoint Inhibitors-induced Colitis, Advanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney Adenocarcinoma | Status: RECRUITING